Gil Blum
Stock Analyst at Needham
(3.64)
# 827
Out of 5,044 analysts
425
Total ratings
40.59%
Success rate
9.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRIX Nurix Therapeutics | Maintains: Buy | $27 → $26 | $11.85 | +119.41% | 26 | Oct 22, 2025 | |
| CELC Celcuity | Reiterates: Buy | $70 | $74.51 | -6.05% | 21 | Oct 20, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.51 | +562.25% | 30 | Oct 20, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $18 | $4.71 | +282.17% | 7 | Oct 17, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $81 | $63.31 | +27.94% | 25 | Oct 10, 2025 | |
| ABSI Absci | Maintains: Buy | $9 → $8 | $4.43 | +80.59% | 5 | Aug 13, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $86.62 | +21.22% | 23 | Dec 10, 2024 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $1.44 | - | 9 | Oct 27, 2025 | |
| IMAB I-Mab | Suspends: Buy | $6 | $4.63 | +29.59% | 18 | Oct 24, 2025 | |
| TSHA Taysha Gene Therapies | Reiterates: Buy | $10 | $4.96 | +101.61% | 31 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $14 | $8.81 | +58.91% | 7 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $5.94 | +34.68% | 25 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.83 | +157.29% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.14 | +367.29% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $23.77 | - | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.85 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $5 | $2.07 | +141.55% | 19 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $8.35 | +379.33% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $33.43 | +112.38% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.05 | +339.02% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.93 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.27 | +295.26% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $11.22 | +327.81% | 9 | Aug 2, 2024 |
Nurix Therapeutics
Oct 22, 2025
Maintains: Buy
Price Target: $27 → $26
Current: $11.85
Upside: +119.41%
Celcuity
Oct 20, 2025
Reiterates: Buy
Price Target: $70
Current: $74.51
Upside: -6.05%
Autolus Therapeutics
Oct 20, 2025
Reiterates: Buy
Price Target: $10
Current: $1.51
Upside: +562.25%
Artiva Biotherapeutics
Oct 17, 2025
Reiterates: Buy
Price Target: $18
Current: $4.71
Upside: +282.17%
CRISPR Therapeutics AG
Oct 10, 2025
Reiterates: Buy
Price Target: $81
Current: $63.31
Upside: +27.94%
Absci
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $4.43
Upside: +80.59%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $86.62
Upside: +21.22%
Fate Therapeutics
Oct 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.44
Upside: -
I-Mab
Oct 24, 2025
Suspends: Buy
Price Target: $6
Current: $4.63
Upside: +29.59%
Taysha Gene Therapies
Oct 17, 2025
Reiterates: Buy
Price Target: $10
Current: $4.96
Upside: +101.61%
Sep 18, 2025
Upgrades: Buy
Price Target: $14
Current: $8.81
Upside: +58.91%
Sep 11, 2025
Reiterates: Buy
Price Target: $8
Current: $5.94
Upside: +34.68%
Aug 13, 2025
Reiterates: Buy
Price Target: $15
Current: $5.83
Upside: +157.29%
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $2.14
Upside: +367.29%
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $23.77
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.85
Upside: -
Jul 10, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $2.07
Upside: +141.55%
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $8.35
Upside: +379.33%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $33.43
Upside: +112.38%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $2.05
Upside: +339.02%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.93
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.27
Upside: +295.26%
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $11.22
Upside: +327.81%